Clinical Trial Update: Confirmatory Study of NeoCart in Knee Cartilage Repair [Phase 3]

View source ↗

Summary

Phase 3 confirmatory trial for NeoCart in knee cartilage repair was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defects of the Knee

Drugs mentioned

• NeoCart

Snippet

Sponsor: Histogenics Corporation | Conditions: Articular Cartilage Defects in the Knee Joint | Phase 3 | Status: TERMINATED